NBTXR3 Radiation Enhancing Hafnium Oxide Nanoparticles Activated By Radiotherapy In Cisplatin-Ineligible Patients With Locally Advanced HNSCC: A Phase I Trial

被引：0

作者：

Le Tourneau, C. ^{[1
]}

Calugaru, V. ^{[1
]}

Borcoman, E. ^{[1
]}

Moreno, V. ^{[2
]}

Calvo, E. ^{[3
]}

Liem, X. ^{[4
]}

Salas, S. ^{[5
]}

Doger, B. ^{[3
]}

Choussy, O. ^{[1
]}

Lesnik, M. ^{[1
]}

Mirabel, X. ^{[6
]}

Badois, N. ^{[1
]}

Krhili, S. ^{[1
]}

Blomkvist, J. ^{[7
]}

Fakhry, N. ^{[8
]}

Kam, S. Wong Hee ^{[5
]}

Hoffmann, C. ^{[1
]}

机构：

[1] Inst Curie, Paris, France

[2] Hosp Fdn Jimenez Diaz, Madrid, Spain

[3] START Madrid, Madrid, Spain

[4] Univ Montreal, Montreal, PQ, Canada

[5] Timone Hosp, AP HM, Marseille, France

[6] Ctr Oscar Lambret, Lille, France

[7] Nanobiotix SA, Paris, France

[8] Hop La Timone, Marseille, France

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2020年 / 108卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3843

引用

页码：E792 / E792

页数：1

共 50 条

[1] Phase I study of functionalized hafnium oxide nanoparticles (NBTXR3) activated by radiotherapy in cisplatin-ineligible locally advanced HNSCC patients.
Le Tourneau, Christophe
Calugaru, Valentin
Takacsi-Nagy, Zoltan
Liem, Xavier
Papai, Zsuzsanna
Fijuth, Jacek
Moreno, Victor
Giralt, Jordi
Salas, Sebastien
Poissonnet, Gilles
Calvo, Emiliano
Doger, Bernard
Choussy, Olivier
Mirabel, Xavier
Krhili, Samar
Bernois, Katell
Fakhry, Nicolas
Wong-Hee-Kam, Stephanie
Borcoman, Edith
Hoffmann, Caroline
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[2] NBTXR3 activated by radiotherapy in cisplatin-ineligible locally advanced HNSCC patients
Le Tourneau, C.
Calugaru, V.
Takacsi-Nagy, Z.
Liem, X.
Papai, Z.
Moreno, V.
Brana, I.
Salas, S.
Poissonnet, G.
Calvo, E.
Doger, B.
Choussy, O.
Mirabel, X.
Krhili, S.
Bernois, K.
Fakhry, N.
Kam, S. Wong Hee
Borcoman, E.
Hoffmann, C.
[J]. RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S399 - S399
[3] Radiation enhancing hafnium oxide nanoparticles (NBTXR3) for the treatment of cisplatin-ineligible locally advanced HNSCC patients: a phase I dose expansion study
Le Tourneau, Christophe
Calugaru, Valentin
Moreno, Victor
Calvo, Emiliano
Liem, Xavier
Salas, Sebastien
Doger, Bernard
Jouffroy, Thomas
Mirabel, Xavier
Rodriguez, Jose
Chilles, Anne
Bernois, Katell
Fakhry, Nicolas
Kam, Stephanie Wong Hee
Hoffmann, Caroline
[J]. ORAL ONCOLOGY, 2021, 118
[4] Phase I Study of Novel Radioenhancer NBTXR3 Activated by Radiotherapy in Cisplatin-Ineligible Locally Advanced HNSCC Patients
Le Tourneau, C.
Calugaru, V.
Takacsi-Nagy, Z.
Liem, X.
Papai, Z.
Fijuth, J.
Garcia, V. Moreno
Garcia, I. Brana
Salas, S.
Poissonnet, G.
Calvo, E.
Doger, B.
Choussy, O.
Mirabel, X.
Krhili, S.
Bernois, K.
Fakhry, N.
Kam, S. Wong Hee
Borcoman, E.
Hoffmann, C.
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E392 - E392
[5] Phase I trial of hafnium oxide nanoparticles activated by radiotherapy in cisplatin-ineligible locally advanced HNSCC patients.
Le Tourneau, Christophe
Calugaru, Valentin
Borcoman, Edith
Moreno, Victor
Calvo, Emiliano
Liem, Xavier
Salas, Sebastien
Doger, Bernard
Choussy, Olivier
Lesnik, Maria
Mirabel, Xavier
Badois, Nathalie
Krhili, Samar
Blomkvist, Josefin
Fakhry, Nicolas
Wong-Hee-Kam, Stephanie
Hoffmann, Caroline
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[6] Novel Radioenhancer NBTXR3 Activated by Radiotherapy in Cisplatin-Ineligible Locally Advanced HNSCC Patients: Final Results of a Phase I Trial
Le Tourneau, C.
Takacsi-Nagy, Z.
Finzi, L.
Liem, X.
Calugaru, V.
Moreno, V.
Calvo, E.
Salas, S.
Doger, B.
Dubray-Vautrin, A.
Mirabel, X.
Badois, N.
Chilles, A.
Fakhry, N.
Kam, S. Wong Hee
Houdas, L.
Debard, A.
Vivar, O. I.
Farber, L. A.
Lesnik, M.
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : S99 - S99
[7] Novel Radioenhancer NBTXR3 Activated by Radiotherapy in Cisplatin-Ineligible Locally Advanced HNSCC Patients: Final and Exploratory Results of a Phase I Trial
Le Tourneau, C.
Liem, X.
Nguyen, T. V. F.
El Bedoui, S.
Salas, S.
Serrahima, M. Plana
Mirabel, X.
Kam, S. Wong Hee
Houdas, L.
Debard, A.
Vivar, O. I.
Farber, L. A.
Thariat, J. O.
Lesnik, M.
Helferich, F.
Herczeg, A.
Papai, Z.
Fijuth, J.
Takacsi-Nagy, Z.
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (05): : E6 - E6
[8] RT-activated hafnium oxide nanoparticles in cisplatin-ineligible locally advanced HNSCC patients
Le Tourneau, C.
Calugaru, V.
Borcoman, E.
Moreno, V.
Calvo, E.
Liem, X.
Salas, S.
Doger, B.
Jouffroy, T.
Mirabel, X.
Rodriguez, J.
Chilles, A.
Bernois, K.
De Rink, M.
Fafhry, N.
Kam, S. Wong Hee
Hoffmann, C.
[J]. RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S312 - S312
[9] Hafnium oxide nanoparticles (NBTXR3) activated by radiotherapy for the treatment of frail and/or elderly patients with locally advanced HNSCC: a phase I/II study
Le Tourneau, C.
Calugaru, V.
Borcoman, E.
Moreno, V.
Calvo, E.
Liem, X.
Salas, S.
Doger, B.
Jouffroy, T.
Mirabel, X.
Rodriguez, J.
Chilles, A.
Bernois, K.
De Rink, M.
Baskin-Bey, E.
Fakhry, N.
Kam, S. Wong Hee
Hoffmann, C.
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 106 (05): : 1142 - 1143
[10] Antitumor activity of the radioenhancer NBTXR3 on injected lesions to estimate overall survival: Exploratory analyses from a phase I in cisplatin-ineligible locally advanced HNSCC patients
Le Tourneau, C.
Takacsi-Nagy, Z.
Liem, X.
Calugaru, V.
Moreno Garcia, V.
Calvo, E.
Salas, S.
Doger De Speville, B.
Dubray-Vautrin, A.
Mirabel, X.
Badois, N.
Chilles, A.
Fakhry, N.
Hee Kam, S. Wong
Debard, A.
Serra, A.
Finzi, L.
Vivar, O. I.
Farber, L. A.
Lesnik, M.
[J]. ANNALS OF ONCOLOGY, 2023, 34 : S568 - S569

← 1 2 3 4 5 →